ASSOCIACAO OCEANO VERDE LABORATORIO COLABORATIVO PARA O DESENVOLVIMENTO DE TECNOLOGIAS E PRODUTOS VERDES DO OCEANO

Their core work

GreenCoLAB is a Portuguese collaborative research laboratory based in Faro that focuses on turning marine algae — both micro and macro — into commercially viable products for food, feed, and human health. Their core work involves developing and validating algae-based protein ingredients as sustainable alternatives to conventional food and feed sources, as well as isolating bioactive compounds from algae that can prevent or treat conditions such as inflammatory bowel disease. As a "Laboratorio Colaborativo," they operate at the intersection of marine biology, food technology, and applied health science, bridging academic research and industrial application. Their projects run in collaboration with large European consortia, where they contribute specialized Portuguese marine biotechnology expertise.

What they specialise in

How they've shifted over time

GreenCoLAB entered H2020 research through ProFuture (2019) with a clear food-systems angle — microalgae as a scalable, sustainable source of protein for food and animal feed. By 2021, their involvement in Algae4IBD marked a significant pivot: the keywords shifted from "protein, sustainability, food, feed" toward "inflammatory bowel disease, microbiome, pain, functional food," signaling entry into therapeutic and nutraceutical territory. This trajectory suggests the lab is moving beyond commodity ingredient production and toward higher-value health applications where algae compounds can be positioned as prevention or treatment tools.

GreenCoLAB is shifting from volume-driven sustainable protein toward precision health applications — partners looking for algae expertise at the food-pharma interface will find increasing relevance here over the next 3–5 years.

How they like to work

GreenCoLAB has never led an H2020 project, entering both projects as participant or third party — a pattern consistent with a young collaborative laboratory that contributes specialized algae expertise to larger, multinational research efforts rather than driving consortium strategy. Despite only two projects, they have accumulated 54 unique consortium partners across 17 countries, which reflects participation in large RIA and IA projects with broad partner bases. Their third-party role in Algae4IBD suggests they may provide specific infrastructure, biomass supply, or testing capability that larger partners depend on but don't hold in-house.

GreenCoLAB has reached 54 unique partners across 17 countries through just two projects, indicating integration into large European research networks rather than bilateral collaborations. No dominant geographic cluster is visible from the data, suggesting their partners are distributed across the EU.

What sets them apart

GreenCoLAB is one of the few Portuguese collaborative laboratories with a dedicated ocean-biotechnology mandate, giving them a natural advantage in sourcing and characterizing Atlantic marine species — a resource base that most landlocked European research centers cannot replicate. Their combination of food-ingredient science (ProFuture) and therapeutic compound development (Algae4IBD) makes them useful to a wider range of consortia than a single-track algae lab would be. For a consortium building around blue bioeconomy, sustainable protein, or gut-health functional foods, GreenCoLAB offers Portuguese marine access plus cross-domain algae processing expertise in a single partner.

Highlights from their portfolio

• ProFuture
  Their only directly funded H2020 project (EUR 117,390), focused on scaling microalgae protein ingredients — a commercially strategic topic given the global push to replace animal protein in food and feed supply chains.
• Algae4IBD
  Runs until 2026 and targets inflammatory bowel disease treatment via algae biocompounds — an unusual intersection of marine biotechnology and clinical medicine that broadens GreenCoLAB's positioning beyond food science.